Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 117

1.

Evidence for a role of the PD-1:PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinoma.

Lyford-Pike S, Peng S, Young GD, Taube JM, Westra WH, Akpeng B, Bruno TC, Richmon JD, Wang H, Bishop JA, Chen L, Drake CG, Topalian SL, Pardoll DM, Pai SI.

Cancer Res. 2013 Mar 15;73(6):1733-41. doi: 10.1158/0008-5472.CAN-12-2384. Epub 2013 Jan 3.

PMID:
23288508
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

PD-1-expressing tumor-infiltrating T cells are a favorable prognostic biomarker in HPV-associated head and neck cancer.

Badoual C, Hans S, Merillon N, Van Ryswick C, Ravel P, Benhamouda N, Levionnois E, Nizard M, Si-Mohamed A, Besnier N, Gey A, Rotem-Yehudar R, Pere H, Tran T, Guerin CL, Chauvat A, Dransart E, Alanio C, Albert S, Barry B, Sandoval F, Quintin-Colonna F, Bruneval P, Fridman WH, Lemoine FM, Oudard S, Johannes L, Olive D, Brasnu D, Tartour E.

Cancer Res. 2013 Jan 1;73(1):128-38. doi: 10.1158/0008-5472.CAN-12-2606. Epub 2012 Nov 7.

PMID:
23135914
[PubMed - indexed for MEDLINE]
Free Article
3.

Interferon-γ-induced PD-L1 surface expression on human oral squamous carcinoma via PKD2 signal pathway.

Chen J, Feng Y, Lu L, Wang H, Dai L, Li Y, Zhang P.

Immunobiology. 2012 Apr;217(4):385-93. doi: 10.1016/j.imbio.2011.10.016. Epub 2011 Nov 3.

PMID:
22204817
[PubMed - indexed for MEDLINE]
4.

The interplay between HPV and host immunity in head and neck squamous cell carcinoma.

Andersen AS, Koldjaer Sølling AS, Ovesen T, Rusan M.

Int J Cancer. 2014 Jun 15;134(12):2755-63. doi: 10.1002/ijc.28411. Epub 2013 Aug 29. Review.

PMID:
23913554
[PubMed - indexed for MEDLINE]
5.

Human papillomavirus (HPV) in head and neck cancer. An association of HPV 16 with squamous cell carcinoma of Waldeyer's tonsillar ring.

Paz IB, Cook N, Odom-Maryon T, Xie Y, Wilczynski SP.

Cancer. 1997 Feb 1;79(3):595-604.

PMID:
9028373
[PubMed - indexed for MEDLINE]
6.

Systemic and local human papillomavirus 16-specific T-cell immunity in patients with head and neck cancer.

Heusinkveld M, Goedemans R, Briet RJ, Gelderblom H, Nortier JW, Gorter A, Smit VT, Langeveld AP, Jansen JC, van der Burg SH.

Int J Cancer. 2012 Jul 15;131(2):E74-85. doi: 10.1002/ijc.26497. Epub 2011 Nov 19.

PMID:
22020783
[PubMed - indexed for MEDLINE]
7.

Effect of human papillomavirus-16 infection on CD8+ T-cell recognition of a wild-type sequence p53264-272 peptide in patients with squamous cell carcinoma of the head and neck.

Sirianni N, Ha PK, Oelke M, Califano J, Gooding W, Westra W, Whiteside TL, Koch WM, Schneck JP, DeLeo A, Ferris RL.

Clin Cancer Res. 2004 Oct 15;10(20):6929-37.

PMID:
15501971
[PubMed - indexed for MEDLINE]
Free Article
8.

Antitumor activity of human papillomavirus type 16 E7-specific T cells against virally infected squamous cell carcinoma of the head and neck.

Albers A, Abe K, Hunt J, Wang J, Lopez-Albaitero A, Schaefer C, Gooding W, Whiteside TL, Ferrone S, DeLeo A, Ferris RL.

Cancer Res. 2005 Dec 1;65(23):11146-55.

PMID:
16322265
[PubMed - indexed for MEDLINE]
Free Article
9.

Human papillomavirus-positive tonsillar carcinomas: a different tumor entity?

Klussmann JP, Weissenborn SJ, Wieland U, Dries V, Eckel HE, Pfister HJ, Fuchs PG.

Med Microbiol Immunol. 2003 Aug;192(3):129-32. Epub 2002 Sep 14.

PMID:
12920586
[PubMed - indexed for MEDLINE]
10.

Clinical significance and therapeutic potential of the programmed death-1 ligand/programmed death-1 pathway in human pancreatic cancer.

Nomi T, Sho M, Akahori T, Hamada K, Kubo A, Kanehiro H, Nakamura S, Enomoto K, Yagita H, Azuma M, Nakajima Y.

Clin Cancer Res. 2007 Apr 1;13(7):2151-7.

PMID:
17404099
[PubMed - indexed for MEDLINE]
Free Article
11.

Detection of transcriptionally active high-risk HPV in patients with head and neck squamous cell carcinoma as visualized by a novel E6/E7 mRNA in situ hybridization method.

Bishop JA, Ma XJ, Wang H, Luo Y, Illei PB, Begum S, Taube JM, Koch WM, Westra WH.

Am J Surg Pathol. 2012 Dec;36(12):1874-82. doi: 10.1097/PAS.0b013e318265fb2b.

PMID:
23060353
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas.

van Houten VM, Snijders PJ, van den Brekel MW, Kummer JA, Meijer CJ, van Leeuwen B, Denkers F, Smeele LE, Snow GB, Brakenhoff RH.

Int J Cancer. 2001 Jul 15;93(2):232-5.

PMID:
11410871
[PubMed - indexed for MEDLINE]
13.

Evidence for a causal association between human papillomavirus and a subset of head and neck cancers.

Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, Zahurak ML, Daniel RW, Viglione M, Symer DE, Shah KV, Sidransky D.

J Natl Cancer Inst. 2000 May 3;92(9):709-20.

PMID:
10793107
[PubMed - indexed for MEDLINE]
Free Article
14.

The relationship between human papillomavirus status and other molecular prognostic markers in head and neck squamous cell carcinomas.

Kong CS, Narasimhan B, Cao H, Kwok S, Erickson JP, Koong A, Pourmand N, Le QT.

Int J Radiat Oncol Biol Phys. 2009 Jun 1;74(2):553-61. doi: 10.1016/j.ijrobp.2009.02.015.

PMID:
19427557
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

PD-1 blockage delays murine squamous cell carcinoma development.

Belai EB, de Oliveira CE, Gasparoto TH, Ramos RN, Torres SA, Garlet GP, Cavassani KA, Silva JS, Campanelli AP.

Carcinogenesis. 2014 Feb;35(2):424-31. doi: 10.1093/carcin/bgt305. Epub 2013 Sep 12.

PMID:
24031027
[PubMed - indexed for MEDLINE]
16.

Verrucous carcinomas of the head and neck, including those with associated squamous cell carcinoma, lack transcriptionally active high-risk human papillomavirus.

Patel KR, Chernock RD, Zhang TR, Wang X, El-Mofty SK, Lewis JS Jr.

Hum Pathol. 2013 Nov;44(11):2385-92. doi: 10.1016/j.humpath.2013.07.011. Epub 2013 Sep 24.

PMID:
24071016
[PubMed - indexed for MEDLINE]
17.

B7-H1 expression model for immune evasion in human papillomavirus-related oropharyngeal squamous cell carcinoma.

Ukpo OC, Thorstad WL, Lewis JS Jr.

Head Neck Pathol. 2013 Jun;7(2):113-21. doi: 10.1007/s12105-012-0406-z. Epub 2012 Nov 20.

PMID:
23179191
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

PD-1 blockage reverses immune dysfunction and hepatitis B viral persistence in a mouse animal model.

Tzeng HT, Tsai HF, Liao HJ, Lin YJ, Chen L, Chen PJ, Hsu PN.

PLoS One. 2012;7(6):e39179. doi: 10.1371/journal.pone.0039179. Epub 2012 Jun 22.

PMID:
22761734
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Programmed death receptor-1/programmed death receptor ligand-1 blockade after transient lymphodepletion to treat myeloma.

Kearl TJ, Jing W, Gershan JA, Johnson BD.

J Immunol. 2013 Jun 1;190(11):5620-8. doi: 10.4049/jimmunol.1202005. Epub 2013 Apr 24.

PMID:
23616570
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Human brain endothelial cells endeavor to immunoregulate CD8 T cells via PD-1 ligand expression in multiple sclerosis.

Pittet CL, Newcombe J, Prat A, Arbour N.

J Neuroinflammation. 2011 Nov 8;8:155. doi: 10.1186/1742-2094-8-155.

PMID:
22067141
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk